Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michael Graner to Brain Neoplasms

This is a "connection" page, showing publications Michael Graner has written about Brain Neoplasms.

 
Connection Strength
 
 
 
2.100
 
  1. Graner MW. Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized Influence. Annu Rev Genomics Hum Genet. 2019 08 31; 20:331-357.
    View in: PubMed
    Score: 0.385
  2. Redzic JS, Gomez JD, Hellwinkel JE, Anchordoquy TJ, Graner MW. Proteomic analyses of brain tumor cell lines amidst the unfolded protein response. Oncotarget. 2016 Jul 26; 7(30):47831-47847.
    View in: PubMed
    Score: 0.319
  3. Graner MW. The unfolded protein response in glioblastomas: passing the stress test. CNS Oncol. 2013 Nov; 2(6):469-72.
    View in: PubMed
    Score: 0.264
  4. Graner MW, Raynes DA, Bigner DD, Guerriero V. Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces. Cancer Sci. 2009 Oct; 100(10):1870-9.
    View in: PubMed
    Score: 0.196
  5. Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, Bigner DD. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009 May; 23(5):1541-57.
    View in: PubMed
    Score: 0.189
  6. Graner MW, Cumming RI, Bigner DD. The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequences. J Neurosci. 2007 Oct 17; 27(42):11214-27.
    View in: PubMed
    Score: 0.174
  7. Graner MW, Bigner DD. Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology. Expert Rev Anticancer Ther. 2006 May; 6(5):679-95.
    View in: PubMed
    Score: 0.157
  8. Graner MW, Bigner DD. Chaperone proteins and brain tumors: potential targets and possible therapeutics. Neuro Oncol. 2005 Jul; 7(3):260-78.
    View in: PubMed
    Score: 0.148
  9. Zhou W, Craft J, Ojemann A, Bergen L, Graner A, Gonzales A, He Q, Kopper T, Smith M, Graner MW, Yu X. Glioblastoma Extracellular Vesicle-Specific Peptides Inhibit EV-Induced Neuronal Cytotoxicity. Int J Mol Sci. 2022 Jun 28; 23(13).
    View in: PubMed
    Score: 0.120
  10. Marshall D, Mitchell DA, Graner MW, Bigner DD. Immunotherapy of brain tumors. Handb Clin Neurol. 2012; 104:309-30.
    View in: PubMed
    Score: 0.058
  11. Vega EA, Graner MW, Sampson JH. Combating immunosuppression in glioma. Future Oncol. 2008 Jun; 4(3):433-42.
    View in: PubMed
    Score: 0.045
  12. Everson RG, Graner MW, Gromeier M, Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS, Friedman AH, Bigner DD, Sampson JH. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma. Expert Rev Anticancer Ther. 2008 May; 8(5):717-32.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)